Activated killer monocytes: use in clinical trials.
Lacerna
L V
LV
National Cancer Institute, Frederick, Maryland.
Sugarbaker
P H
PH
Stevenson
H C
HC
D006801:Humans; D016219:Immunotherapy, Adoptive; D007694:Killer Cells, Natural / Q000276:immunology*; D009000:Monocytes / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*